TFF3 and breast carcinoma: Again, TFF3 has been reported to promote motility in a range of different cell types including Madin-Darby canine kidney cells (MDCK) [48, 49], rat fibroblastic cells [50], normal and transformed bronchial epithelial cells colonic [51] and mammary carcinoma cells [16, 19].